EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance

Simona Gabriela Duta-Ion, Ioana Ruxandra Juganaru, Iulian Andrei Hotinceanu, Andra Dan, Livia Malina Burtavel, Madalin Codrut Coman, Ina Ofelia Focsa iD, Andra Giorgiana Zaruha, Patricia Christina Codreanu, Laurentiu Camil Bohiltea, Viorica Elena Radoi

International Journal of Molecular Sciences · 21.11.2024 · 25 (23) · 12507

DOI: 10.3390/ijms252312507 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.11.2024. Verfasst von Simona Gabriela Duta-Ion und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Molecular Targeted Therapy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Carol Davila” University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) arises through a combination of genetic and epigenetic alterations that affect key pathways involved in tumor growth and progression. This review examines the major molecular pathways driving CRC, including Chromosomal Instability (CIN), Microsatellite Instability (MSI), and the CpG Island Methylator Phenotype (CIMP). Key mutations in genes such as APC, KRAS, NRAS, BRAF, and TP53 activate signaling pathways like Wnt, EGFR, and PI3K/AKT, contributing to tumorigenesis and influencing responses to targeted therapies. Resistance mechanisms, including mutations that bypass drug action, remain challenging in CRC treatment. This review highlights the role of molecular profiling in guiding the use of targeted therapies such as tyrosine kinase inhibitors and immune checkpoint inhibitors. Novel combination treatments are also discussed as strategies to improve outcomes and overcome resistance. Understanding these molecular mechanisms is critical to advancing personalized treatment approaches in CRC and improving patient prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDrug Resistance, NeoplasmMolecular Targeted TherapyHumansMicrosatellite InstabilitySignal TransductionChromosomal InstabilityMutation

Stichwörter der Autor:innen

APC pathwayBRAF mutationsKRAS mutationsMSI/dMMRPI3K/AKT/mTOR pathwaycolon cancerimmunotherapytargeted therapy

Autor:innen und Institutionen

  • Department of Medical Genetics, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
  • "Alessandrescu-Rusescu" National Institute for Maternal and Child Health, 20382 Bucharest, Romania.

ORCID-Profile: Ina Ofelia Focsa

Förderung

  • “Carol Davila” University of Medicine and Pharmacy

Zitieren

APA

Duta-Ion, S. G., Juganaru, I. R., Hotinceanu, I. A., Dan, A., Burtavel, L. M., Coman, M. C., Focsa, I. O., Zaruha, A. G., Codreanu, P. C., Bohiltea, L. C., & Radoi, V. E. (2024). Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance. International Journal of Molecular Sciences, 25(23), 12507. https://doi.org/10.3390/ijms252312507

Vancouver

Duta-Ion SG, Juganaru IR, Hotinceanu IA, Dan A, Burtavel LM, Coman MC, et al. Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance. International Journal of Molecular Sciences. 2024;25(23):12507. doi:10.3390/ijms252312507

BibTeX
@article{DutaIon2024,
  author = {Duta-Ion, Simona Gabriela and Juganaru, Ioana Ruxandra and Hotinceanu, Iulian Andrei and Dan, Andra and Burtavel, Livia Malina and Coman, Madalin Codrut and Focsa, Ina Ofelia and Zaruha, Andra Giorgiana and Codreanu, Patricia Christina and Bohiltea, Laurentiu Camil and Radoi, Viorica Elena},
  title = {Redefining Therapeutic Approaches in Colorectal Cancer: Targeting Molecular Pathways and Overcoming Resistance},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {23},
  pages = {12507},
  doi = {10.3390/ijms252312507}
}
Kostenlos starten →